Back

P318
Phosphoinositide 3-kinase gamma inhibition as a novel strategy to reactivate targeted autophagy and limit Doxorubicin-induced cardiotoxicity

Cardiovascular Research

23 April 2018
Organised by: Logo
Read full article
ESC Journals

Contributors

M Li
M Li

Author

V Sala
V Sala

Author

N Pianca
N Pianca

Author

S Sciarretta
S Sciarretta

Author

F Morello
F Morello

Author

M Sandri
M Sandri

Author

M Mongillo
M Mongillo

Author

T Zaglia
T Zaglia

Author

E Hirsch
E Hirsch

Author

A Ghigo
A Ghigo

Author

You may be interested in
thumbnail
Congress Presentation
Cardiometabolic rewiring in the context of doxorubicin-induced cardiotoxicity: fuel preference changes from fatty acids to glucose oxidation
26 August 2023
thumbnail
Congress Presentation
Impaired autophagy mechanisms associated with phospholamban-R14del disease
12 April 2024
thumbnail
Congress Session
Cardio-oncology – hidden in plain sight
19 May 2025
thumbnail
Congress Presentation
Targeted cardiac inactivation of Guanylate binding protein 5 (GBP5) protects from cardiotoxicity after doxorubicin treatment
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources